BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36416960)

  • 1. The neurocognitive disorder cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup.
    Baumann B; Lipka T; Jänner M; Kujovic M
    Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):941-952. PubMed ID: 36416960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertension and obstructive sleep apnea counteracts cognitive decline in common neurocognitive disorders in diagnosis-related patterns.
    Kujovic M; Lipka T; Zalman M; Baumann L; Jänner M; Baumann B
    Sci Rep; 2023 May; 13(1):7556. PubMed ID: 37160982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults.
    Eramudugolla R; Mortby ME; Sachdev P; Meslin C; Kumar R; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):15. PubMed ID: 28259179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10-year follow-up study.
    Bessi V; Giacomucci G; Mazzeo S; Bagnoli S; Padiglioni S; Balestrini J; Tomaiuolo G; Piaceri I; Carraro M; Bracco L; Sorbi S; Nacmias B
    Eur J Neurol; 2021 Jan; 28(1):56-65. PubMed ID: 32896064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, subjective cognitive decline, and the risk of neurocognitive disorders.
    Liew TM
    Alzheimers Res Ther; 2019 Aug; 11(1):70. PubMed ID: 31399132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Caregiver Burden Evolution, for Patients With Subjective Cognitive Decline or Neurocognitive Disorders: A Longitudinal Analysis.
    Dauphinot V; Ravier A; Novais T; Delphin-Combe F; Mouchoux C; Krolak-Salmon P
    J Am Med Dir Assoc; 2016 Nov; 17(11):1037-1043. PubMed ID: 27575984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Cognitive Decline Precedes the Advent of Subjective Cognitive Decline in the Evolution of Alzheimer's Disease.
    Reisberg B; Shao Y; Moosavi M; Kenowsky S; Vedvyas A; Marsh K; Bao J; Buj M; Torossian C; Kluger A; Vedvyas G; Oo T; Malik F; Arain F; Masurkar AV; Wisniewski T
    Dement Geriatr Cogn Disord; 2020; 49(1):16-21. PubMed ID: 32388509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.
    Heinik J; Kavé G
    Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild Neurocognitive Disorder: An Old Wine in a New Bottle.
    Stokin GB; Krell-Roesch J; Petersen RC; Geda YE
    Harv Rev Psychiatry; 2015; 23(5):368-76. PubMed ID: 26332219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
    Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
    PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Operational Definitions for Mild Cognitive Impairment.
    Polcher A; Wolfsgruber S; Peters O; Frölich L; Wiltfang J; Kornhuber J; Hüll M; Rüther E; Lewczuk P; Maier W; Jessen F; Wagner M
    J Alzheimers Dis; 2022; 88(4):1663-1678. PubMed ID: 35811516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.